Top 5 Most Read RNS's on Vox Markets for Friday 19th May 2023
If you find this podcast useful please give it a rating and review on iTunes by clicking here
Top 5 Most Read RNS's on Vox Markets for Friday 19th May 2023
1. - Funding and Appointment of Joint Broker
Premier African Minerals announces a further placing to raise £610,000 at 0.925p for the ongoing Zulu Lithium and Tantalum Project Pilot Plant optimisation.
George Roach, Chief Executive Officer, has agreed to participate in the placing at the Placing Price by way of a subscription of £110,000.
2. - NICE recommends CYP2C19 genotyping
genedrive announces that the UK's National Institute for Health and Care Excellence ("NICE") has recommended in draft guidance that CYP2C19 genotyping should be used before clopidogrel administration in the management of ischemic stroke ("IS") patients.
Although the Genedrive® CYP2C19 ID test is in development, the NICE Committee included its predicted performance and pricing in its clinical and economic models.
3. - H1 FY2023 Results and dividend timetable
REVENUE US$335.3m up 0.4%, PROFIT BEFORE TAX US$72.4 m down 41.8% (HY2022: US$124.3 m), INTERIM DIVIDEND US 3 cents.
4. - Drilling Results
Europa Metals announce the first assay results from its ongoing infill diamond drilling programme at the Company's 100% owned Toral Pb, Zn & Ag project.
Significant intersection from drillhole TOD-043 of 8.70m @ 11.03% ZnEq(PbAg)*, including:
o 3.10m @ 20.35% ZnEq(PbAg)*
5. - Debt capitalisation of amounts owed by KDR
Conroy Gold and Natural Resources has acquired an equity interest in AIM-quoted Karelian Diamond Resources through entering into a debt capitalisation arrangement, including the issue of convertible loan notes, with Karelian Diamonds.
Capitalisation of debt amounting to £125,000 into new ordinary shares in Karelian Diamond Resources plc at a price of 2.5p per share
Exchange of debt amounting to £112,500 into a convertible loan of £112,500 in Karelian Diamond Resources plc.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.